Biological Products, (No Diagnostic Substances) · DE · CIK 1368514
Manufactures, markets, and develops specialty biologics for immunodeficient patients and those at risk for infectious diseases
Comparable business profile · signals at a glance
In the 90 days to Mar 16, 2026: 1 insider bought $217K · 2 sold $814K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 | Grossman Adam SPresident and CEO | Sell | 15,000 | $15.16 | $227K |
| Mar 16, 2026 | Grossman Adam SPresident and CEO | Sell | 6,000 | $15.16 | $91K |
| Mar 9, 2026 | Kestenberg-Messina Kaitlin M.COO and SVP, Compliance | Sell | 10,096 | $15.63 | $158K |
| Mar 6, 2026 | Elms SteveDirector | Buy | 7,000 | $15.39 | $108K |
| Mar 5, 2026 | Elms SteveDirector | Buy | 7,000 | $15.67 | $110K |
| Feb 17, 2026 | Grossman Adam SPresident and CEO | Sell | 15,000 | $16.08 | $241K |
| Feb 17, 2026 | Grossman Adam SPresident and CEO | Sell | 6,000 | $16.08 | $96K |
| Dec 15, 2025 | Grossman Adam SPresident and CEO | Sell | 15,000 | $19.79 | $297K |
| Dec 15, 2025 | Grossman Adam SPresident and CEO | Sell | 6,000 | $19.79 | $119K |
| Nov 19, 2025 | Grossman Adam SPresident and CEO | Sell | 15,000 | $16.00 | $240K |
| Nov 19, 2025 | Grossman Adam SPresident and CEO | Sell | 6,000 | $16.00 | $96K |
| Oct 24, 2025 | Grossman Adam SPresident and CEO | Sell | 15,000 | $16.00 | $240K |
| Oct 24, 2025 | Grossman Adam SPresident and CEO | Sell | 6,000 | $16.00 | $96K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.